BOSTON, April 4, 2024 /PRNewswire/ -- Haemonetics Corporation (HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced ...

BOSTON, Oct. 10, 2023 /PRNewswire/ -- Haemonetics Corporation (HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, and OpSens ...

JMP Securities analyst David Turkaly reiterated a Buy rating on Haemonetics (HAE – Research Report) today and set a price target of $115.00. David Turkaly provided a Buy rating for Haemonetics ...

Haemonetics will shell out up to 185 million euros ($216 million) to acquire Vivasure Medical, a Galway, Ireland-based medtech that makes arterial closure devices.

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Haemonetics (HAE), which belongs to the Zacks ...

BOSTON, March 5, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical products and solutions to drive better patient ...

Blood products company Haemonetics (NYSE:HAE). will be reporting results tomorrow before market open. Here’s what you need to know. Haemonetics missed analysts’ revenue expectations by 1.3% last ...

Haemonetics (HAE – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael Petusky from Barrington remains neutral on the stock and has a $105.00 ...

Analysts have recently evaluated Haemonetics and provided 12-month price targets. The average target is $87.45, accompanied ...

BOSTON, Jan. 14, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, ...